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Urticaria has been known from antiquity. The disorder was
known to the Arabs as essera and it has found a place in the
writings of Cesius (circa 30 BC–45 AD). Although the condi-
tion was recognised as an entity, its cause was a mystery to the
physicians of those times. It was initially thought to be a
manifestation of idiosyncrasy and later believed to be a form
of neuroses. However, now the pathophysiological basis of
urticaria is well understood. The development of antihistamine
group of drugs, paved the way for the management of urticaria.
Pathophysiology
The role of histamine. Initially, efforts to delineate the
pathogenesis of urticaria focussed on a possible role for histamine.
Intracutaneous injections, of histamine reproduce the pruritic
wheal and flare reaction typical of urticaria. Although the
capacity of antihistamines to inhibit urtication in many instances
is suggestive, it does not firmly prove a role for histamine, since
many of those drugs have additional pharmacological effects
(anti-cholinergic, local anaesthetic, central nervous system
effects etc.). That histamine is an important mediator of urti-
caria is best suggested by studies on physical urticarias. In cold
urticaria, there is a transient elevation of histamine levels in
venous plasma from the chilled extremity as it is warmed. Since
the plasma half life of histamine is less than a minute, it is
not surprising that the level of histamine in the opposite limb
is normal. Further, as there is no such massive discharge of
histamine in other forms of urticaria it follows that the levels
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of histamine in such conditions is essentially normal save the
physical urticarias. Chilling of skin biopsies obtained from
patients with cold urticaria results in basophil histamine release.
Since the basophils also contain other mediators such evidence
cannot be considered as sufficient proof that the cause of the
urticarial lesions is histamine.
Paradoxically, in certain allergic urticarias decreased basophil
counts and whole blood levels of histamine have been reported
with normal levels of plasma histamine. This may be the result
of basophil degranulation and rapid clearance of histamine
from the plasma. Also of interest is the fact that the histamine
content of vesicle fluid at sites of urticarial lesions is high.
Normally the histamine levels in the uninvolved skin is higher
than involved skin areas. It has been suggested that the baso-
phils in such urticarial lesions are “leaky” but this has not
been supported by in vitro studies which have actually demons-
trated a decreased release of histamine by heterologous anti-
IgE antibodies.
The initial enthusiasm that all urticarias could be explained
as a consequence of histamine release faded with the demons-
tration over the years that the vast majority of urticarias
are not IgE mediated–IgE being the chief trigger of basophil
release. This led to the search for non IgE mediated immuno-
logical mechanism as well as non-immunological methods
of histamine release. The current thinking, while acknowledging
that histamine release is the final step in the process of the
development of urticarial lesions recognises that stimuli other
than IgE are capable of causing histamine release. For example,
in cholinergic urticaria acetylcholine released from nerve en-
dings may trigger basophil release while several drugs such
as morphine and codeine can induce histamine release directly
as can trauma.
Complement
Several components of the complement system such as
C5a, C3a and C4a are powerful histamine releasers and it is
conceivable that complement activation can lead to release
of histamine. In fact, in a number of clinical situations where
complement activation has been known to be a significant
aspect of the disease, urticarial lesions have been identified
commonly. These include the cryoglobulinaemias, SLE and
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Sjogren’s syndrome. In addition, a distinct entity known as
hypocomplimentaemic urticarial vasculitis has also been re-
ported.
Other Mediators
In view of the association between aspirin ingestion and the
exacerbation of urticarial lesions it has been suggested that
certain metabolites of arachidonic acid may play and important
pathogenic role in urticaria. Leukotriene D4, in fact, causes
increased vascular permeability in human skin even at very
low concentrations. Other mediators with a putative role in
urticaria include kinins, serotonin and substance ‘P’.
A number of factors can modulate the release of mediators
and some of them are strikingly evident in certain cases. These
include cutaneous vasodilators, drugs and hormones.
The Present Study
In order to study the clinical profile laboratory features
and the role of mediators in urticaria the present study was
conducted at the Allergy Clinic of the Govt. General Hospital,
Madras, South India. This clinic serves as the referral centre
not only for the city of Madras, but also other parts of the
States of Tamil Nadu and neighbouring states.
A total of 615 patients with various forms of urticaria were
studied over a 4 year period. The duration of the disease was
six months or longer, to be considered as chronic urticaria
and to be included in the study. In the present series 479 patients
had urticaria alone (78%), 102 had urticaria and angioedema
(17%) while 34 had angioedema alone (5%) (Table 1). This
is in contrast to the study by Champion 19691, 49% of whose
subjects had a combination of urticaria and angioedema, 40%
Table 1 Urticaria
(615 cases)
Urticaria alone 479 (78%)
Urticaria and angioedema 102 (17%)
Angioedema alone 34 (5%)
Dermographism was present in 105 cases (17%)
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urticaria alone and 11 % angioedema alone. This pattern appears
to be common among adult population in the west. However,
in paediatric populations in the west the pattern of lesions is
similar to that obtaining in the present study; for example,
Harris et al 19832 showed that 85 % children had urticaria alone,
9% had urticaria and angioedema, while only 6% had
angioedema alone. (Table 2)
Table 2.
Champion Harris
1974 1983
Urticaria alone
Urticaria and angioedema
Angioedema alone
40% 85%
49% 6%
11% 9%
There have been conflicting reports regarding the association
between urticaria and other atopic disorders. Several authors3,4,5
found an increased incidence of urticaria among individuals
with a previous history of eczema, hay fever and asthma.
However, Champion and coworkers 19691 found no such in-
creased incidence in chronic urticaria while they did demons-
trate that acute urticaria was commoner in individuals with
a past history of atopy. This prompted investigators to examine
the issue of the extent to which a family history of atopy would
influence the development of urticaria. It has been clearly
shown that a family history of atopy was not a predisposing
feature in chronic urticarias at least.1,6 In the present study
where the population studied consisted chiefly of individuals
with chronic urticaria, no increased incidence of either family  
or personal history of atopic disorders was observed (Table 3).
Table 3. Urticaria and atopy–615 cases
Family history of atopy
Atopic disorders
Allergic rhinitis
Bronchial asthma
Eczema
132 cases (21 %)
174 cases (77 %)
72
36
61
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Associated Disorders
Apart from the skin, wheals may develop at other sites
especially the tongue, soft palate and pharynx. Various neuro-
logical complications have been reported. Cerebral edema
may develop in association with urticaria and angioedema,
Fowler 19627 reported a series of seven patients who developed
changes possibly due to cerebral involvement and included
a patient with headache. In the present series allergic headache
was reported in as many as 34 cases.
Cardiac complications have been discussed by Kanof 19598
who gave a number of references to isolated cases with chest
pain, ECG changes and urticaria. In the present series no ECG
abnormalities were identified in 20 cases studied. However,
hypertension was detected in 24 cases and this is probably
unrelated to the urticaria.
Main and Paterson 19509 described a patient with pan-
creatitis clinically manifest 24 hours after the onset of acute
urticaria. In the present series, diabetes (unrelated to the urti-
caria) was detected in 8 cases (Table 4). This is no different
from the prevalence of diabetes in the general population.
Table 4. Associated disorders–615 cases
Hypertension 24 cases (4 %)
Allergic headache
Pedal edema
Hydrocele
Anaemia
Diabetes
Leprosy
34 cases (55%)
23 cases (3.8%)
11 cases (1.8%)
20 cases (3.25%)
8 cases (1.6 %)
3 cases (0.5%)
Fecal Sepsis
In the present series foci of sepsis were discovered in nearly
a third of the cases (Table 5). However, eradication of the foci
was beneficial in 12 out of 172 cases.
It must, however, be remembered that bacterial infection
was often considered an important etiological feature of chronic
urticaria especially in older literature. However this assump-
tion was based on anecdotal evidence rather than on the basis
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Table 5. Focal sepsis and urticaria (615 cases)
Dental caries 159 (20%)
Sinusitis 37 (6%)
Tonsillitis 13 (2%)
of controlled clinical studies. It has been suggested that some
of the dramatic results reported in older literature were possibly
due to the reaction of the operative trauma or to the natural
history of the disease. 10  Currently, while recognising that every
case of urticaria warrants a thorough clinical examination
one must be wary of expending time and money on futile search
for a presumed focus of sepsis in every such case.
Intestinal Parasites and Urticaria
In Western literature parasites do not figure prominently
in the list of aetiological agents responsible for urticaria. How-
ever, in the present series a significant number of patients (60%
harbored a variety of intestinal parasites and showed remission
of their skin conditions with appropriate antihelminthic or
antiprotozal therapy. The relationship between allergies and
helminthic infection has been debated. One obvious possibility
is that helminthic infection might cause allergic disease, first
by inducing helminth–specific allergic symptoms or by exacer-
bating allergies to non helminth environmental antigens by
potentiating heterologous IgE responses. Alternatively, hel-
minthic infection might have an allergy-inhibiting effect by
saturating mast cell Fc receptors with irrelevant IgE antibodies,
stimulation of blocking antibodies or the desensitisation of
mast celis by circulating parasites allergens.
Epidemiological studies have shown that, at any rate, there
is not a greater prevalence of allergic disorders in helminth
infected than non-infected people, a fact which in itself requires
explanation. The idea that helminth induced IgE might actually
decrease rather than promote allergic disorders developed
from an experimental observation which showed that sensitiza-
tion of human skin for the P.K. test with a specific IgE could
be competitively inhibited with an IgE myeloma protein or its
FCe fragments.
A state of perpetual anaphylaxis would be expected to occur
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with the Continuous presence of parasite specific IgE and para-
sitic allergen in the infected host. That this does not and could
not occur since it would be incompatible with survival is indeed
evidence for a regulatory mechanism ultimately affecting mast
cell degranulation or mediator sensitivity. Many parasites do
at one time or other cause severe allergic symptomatology.
Allergic reactions to other antigens, although perhaps somewhat
constrained, nevertheless do occur in helminth infected indi-
viduals. The picture we see probably reflects a balance of
conflict between the allergy promoting and allergy inhibiting
effects of helminth infection.
Table 6 shows the incidence of various intestinal parasites
in the present series. In many cases there was a gratifying re-
mission of urticarial lesions with treatment of the underlying
helminthiasis. The results of such therapy are shown in Table 7.
Parasites other than intestinal have also been known to be
associated with urticaria. The occurence of urticarial lesions
Table 6. Intestinal parasites and urticaria (615 cases)
Ascaris 168 (27.3%)
E. Histolytica 158 (25.6%)
Ascaris + E. Histolytica 88 (14.3%)
Giardia - Lamblia 44 (7.15%)
Others 30 (4. 87%)
Table 7. Intestinal parasites and urticaria response to treatment
No. Favourable
treated response
Ascaris + EH 39 36 (92%)
Ascaris 40 15 (37.5%)
EH 30 10 (33%)
GL 9 1 (11%)
Ascaris + GL 10 6 (60%)
Anky 7 1 (14.2%)
Total 135 69 (50%)
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in association with malaria has been reported by some workers.11
In the present series one patient had urticarial lesions syn-
chronous with the appearance of a spite in temperature and
demonstration of the parasite in the peripheral smear.
The role of filarial infection was also investigated in the
present study. 24 individuals with urticaria had clinical filarial
disease. Of these 2 had circulating microfilaria and remission
was achieved with Diethyl carbamazine therapy (DEC)–
Table 8. However, the role of DEC in urticaria in such situations
needs to be viewed in the context of its antifilarial as well as
its antiallergic effects.
Table 8. Parasites and urticaria (615 cases)
Filariasis
(2 patients with circulating mF) Malaria
24 cases
5 cases
Drugs and Urticaria
Drug induced urticaria may be the result of several mecha-
nisms operating in the same individual. Further, the same drug
may produce urticaria through different immunological mecha-
nisms. (Penicillin producing urticarial lesions both by type I
and type III reactions in addition to a non-specific mechanisms).
The situation is complicated further when an individual receives
more than one drug or develops urticaria to additives commonly
found in drugs.
Table 9 illustrates the incidence of associations seen between
drug ingestion and the development of urticaria in the present
series. Commonly implicated drugs include penicillin, sulpha
group of compounds and aspirin.
Table 9. Drugs and urticaria–615 cases
Aspirin 9 (1.5%)
Paracetamol 8 (1.4%)
Analgin 15 (2.4%)
Sulpha 15 (2.4%)
Penicillin 11 (1.8%)
B. Complex 6 (1.0%)
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Immunological Investigations
Estimation of serum IgG, IgA and IgM levels in various
types of urticaria showed no significant alteration of these
antibody levels as compared with those obtaining in a control
local population. (Table 10).
Table 10. Immunoglobulins in urticaria
Idiopathic (12)
Parasites (17)
Infection (6)
Atopy (9)
Drugs (4)
Hormonal (4)
Controls : IgA –(172 ± 72)
IgG     –(1295 ± 414) 
IgM  –(192 ± 95)
Mean values IU
IgA IgG IgM
176 1975 187
194 2088 238
224 1800 222
204 2186 187
104 2440 164
269 2115 240
However, serum IgE levels were elevated in virtually all
forms of urticarias (Table 11). The highest levels were seen in
individuals with a personal history of atopy. C3 and C4 levels
in various forms of urticaria were within normal limits when
compared with local controls.
Table 11. Serum IgE levels in urticaria
Idiopathic (11) 2568 ± 1565
Helminthiasis (17) 3169 ± 1999
Atopy ( 8) 5093 ± 2556
Infection ( 4) 3250 ± 2320
Hormonal ( 3) 2716 ± 579
Drugs ( 3) 4600 ± 999
Controls ( 6) 954 ± 236
Management of Urticaria
The mainstay of therapy has been the antihistamine group
of drugs which have been successful in the vast majority of
cases. Corticosteroids have also been useful especially in life
threatening situations such as angioedema. Recently several
drugs have been tried with varying results in urticaria. These
include the H2 blockers such as Cimetidene; Danazol, a modi-
fied androgen and the trycyclic antidepressents. Traditionally
physicians have also used I.V. calcium in the management
of urticaris.
An useful adjunct to the therapy of urticaria has been the
employment of DEC–a drug already found to be useful in aller-
gic diseases such as bronchial asthma13 and allergic rhinitis14
Several cases in this study showed significant improvement
on treatment with this drug when administered in an open trial.
The drug is being assessed for its efficacy in urticaria in a double
blind trial currently.
Table 12. Complement levels in urticaria
C3 g/lit C4 g/lit
Parasites (6) 1.168 0.489
Idiopathic (5) 1.130 0.409
Infection (4) 1.076 0.623
Atopy (4) 1.190 0.538
Controls 0.55–1.20 0.2–0.5
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